Peter M. Hecht
2021 - Cyclerion Therapeutics
In 2021, Peter M. Hecht earned a total compensation of $108.2K as Chief Executive Officer at Cyclerion Therapeutics, a 70% decrease compared to previous year.
Compensation breakdown
| Salary | $100,000 |
|---|---|
| Other | $8,220 |
| Total | $108,220 |
Hecht received $100K in salary, accounting for 92% of the total pay in 2021.
Hecht also received $8.2K in other compensation.
Rankings
In 2021, Peter M. Hecht's compensation ranked 12,242nd out of 12,415 executives tracked by ExecPay. In other words, Hecht earned more than 1.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,242 out of 12,415 | 1st |
Division Manufacturing | 5,430 out of 5,508 | 1st |
Major group Chemicals And Allied Products | 2,355 out of 2,378 | 1st |
Industry group Drugs | 2,078 out of 2,099 | 1st |
Industry Pharmaceutical Preparations | 1,535 out of 1,549 | 1st |
Source: SEC filing on April 26, 2022.
Hecht's colleagues
We found two more compensation records of executives who worked with Peter M. Hecht at Cyclerion Therapeutics in 2021.
News
Cyclerion Therapeutics COO Cheryl Gault's 2022 pay slips 3% to $645K
April 3, 2023
Cyclerion Therapeutics CSO Andreas Busch's 2021 pay slips 3% to $783K
April 26, 2022
Cyclerion Therapeutics CSO Andreas Busch's 2020 pay falls 75% to $807K
April 28, 2021
Ironwood Pharmaceuticals CEO Mark Mallon receives $10M in 2019
April 21, 2020
Ironwood Pharmaceuticals CEO Peter Hecht's 2018 pay slips 14% to $5.2M
April 26, 2019